{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:22:49Z","timestamp":1759530169866},"reference-count":116,"publisher":"Springer Science and Business Media LLC","issue":"13-14","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1007\/s00508-008-0986-5","type":"journal-article","created":{"date-parts":[[2008,8,25]],"date-time":"2008-08-25T10:57:07Z","timestamp":1219661827000},"source":"Crossref","is-referenced-by-count":7,"title":["Pathophysiologie und Therapie der benignen Prostata-Hyperplasie","Pathophysiology and therapy of benign prostatic hyperplasia"],"prefix":"10.1007","volume":"120","author":[{"given":"Natalie","family":"Sampson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Madersbacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,7,1]]},"reference":[{"issue":"Suppl 1","key":"986_CR1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000475324","volume":"25","author":"JT Isaacs","year":"1994","unstructured":"Isaacs JT (1994) Etiology of benign prostatic hyperplasia. Eur Urol 25 [Suppl 1]: 6\u20139","journal-title":"Eur Urol"},{"issue":"2","key":"986_CR2","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000019699","volume":"34","author":"S Madersbacher","year":"1998","unstructured":"Madersbacher S, Haidinger G, Temml C, Schmidbauer CP (1998) Prevalence of lower urinary tract symptoms in Austria as assessed by an open survey of 2,096 men. Eur Urol 34(2): 136\u2013141","journal-title":"Eur Urol"},{"issue":"9","key":"986_CR3","first-page":"379","volume":"112","author":"S Madersbacher","year":"2000","unstructured":"Madersbacher S (2000) Prevalence of lower urinary tract symptoms and urinary incontinence in the elderly: recent data from Austria. Wien Klin Wochenschr 112(9): 379\u2013380","journal-title":"Wien Klin Wochenschr"},{"issue":"1","key":"986_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-5347(17)44709-4","volume":"136","author":"M Caine","year":"1986","unstructured":"Caine M (1986) The present role of alpha-adrenergic blockers in the treatment of benign prostatic hypertrophy. J Urol 136(1): 1\u20134","journal-title":"J Urol"},{"issue":"6","key":"986_CR5","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.eururo.2007.03.034","volume":"51","author":"S Madersbacher","year":"2007","unstructured":"Madersbacher S, Marszalek M, Lackner J, Berger P, Schatzl G (2007) The long-term outcome of medical therapy for BPH. Eur Urol 51(6): 1522\u20131533","journal-title":"Eur Urol"},{"issue":"5","key":"986_CR6","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0302-2838(03)00376-2","volume":"44","author":"KM Verhamme","year":"2003","unstructured":"Verhamme KM, Dieleman JP, Bleumink GS, Bosch JL, Stricker BH, Sturkenboom MC (2003) Treatment strategies, patterns of drug use and treatment discontinuation in men with LUTS suggestive of benign prostatic hyperplasia: the Triumph project. Eur Urol 44(5): 539\u2013545","journal-title":"Eur Urol"},{"key":"986_CR7","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/00000478-198808000-00003","volume":"12","author":"JE McNeal","year":"1988","unstructured":"McNeal JE (1988) Normal histology of the prostate. Am J Surg Pathol 12: 619\u2013633","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"986_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/CS20040241","volume":"108","author":"RM Long","year":"2005","unstructured":"Long RM, Morrissey C, Fitzpatrick JM, Watson RW (2005) Prostate epithelial cell differentiation and its relevance to the understanding of prostate cancer therapies. Clin Sci (Lond) 108(1): 1\u201311","journal-title":"Clin Sci (Lond)"},{"issue":"9\u201310","key":"986_CR9","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1432-0436.2005.00047.x","volume":"73","author":"EJ Tokar","year":"2005","unstructured":"Tokar EJ, Ancrile BB, Cunha GR, Webber MM (2005) Stem\/progenitor and intermediate cell types and the origin of human prostate cancer. Differentiation 73 (9\u201310): 463\u2013473","journal-title":"Differentiation"},{"key":"986_CR10","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.mce.2006.01.021","volume":"260\u2013262","author":"P Berger","year":"2007","unstructured":"Berger P, Gruschwitz M, Spoettl G, Dirnhofer S, Madersbacher S, Gerth R, et al (2007) Human chorionic gonadotropin (hCG) in the male reproductive tract. Mol Cell Endocrinol 260\u2013262: 190\u2013196","journal-title":"Mol Cell Endocrinol"},{"key":"986_CR11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF00307937","volume":"23","author":"PJ Gkonos","year":"1995","unstructured":"Gkonos PJ, Krongrad A, Roos BA (1995) Neuroendocrine peptides in the prostate. Urological Research 23: 81\u201387","journal-title":"Urological Research"},{"issue":"5","key":"986_CR12","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/hupa.2002.124032","volume":"33","author":"M Srodon","year":"2002","unstructured":"Srodon M, Epstein JI (2002) Central zone histology of the prostate: a mimicker of high-grade prostatic intraepithelial neoplasia. Hum Pathol 33(5): 518\u2013523","journal-title":"Hum Pathol"},{"issue":"4","key":"986_CR13","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/j.1464-410X.2006.06427.x","volume":"98","author":"L van der Heul-Nieuwenhuijsen","year":"2006","unstructured":"van der Heul-Nieuwenhuijsen L, Hendriksen PJ, van der Kwast TH, Jenster G (2006) Gene expression profiling of the human prostate zones. BJU Int 98(4): 886\u2013897","journal-title":"BJU Int"},{"issue":"3\u20134","key":"986_CR14","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1023\/A:1021242813374","volume":"21","author":"M Che","year":"2002","unstructured":"Che M, Grignon D (2002) Pathology of prostate cancer. Cancer Metastasis Rev 21(3\u20134): 381\u2013395","journal-title":"Cancer Metastasis Rev"},{"key":"986_CR15","unstructured":"Roehrborn CG, McConnell JD (2002) Etiology, pathophysiology, epidemiology and natural history of benign prostatic hyperplasia. In: Walsh PC, Retik AB, Vaughan ED Jr, Wein AJ (eds) Philadelphia. Campbell\u2019s Urology, pp 1297\u20131336"},{"key":"986_CR16","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s004280050236","volume":"433","author":"H Bonkhoff","year":"1998","unstructured":"Bonkhoff H, Remberger K (1998) Morphogenetic concepts of normal and abnormal growth in the human prostate. Virchows Archiv 433: 195\u2013202","journal-title":"Virchows Archiv"},{"issue":"1 Suppl","key":"986_CR17","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/1097-0142(19920701)70:1+<291::AID-CNCR2820701317>3.0.CO;2-4","volume":"70","author":"DG Bostwick","year":"1992","unstructured":"Bostwick DG, Cooner WH, Denis L, Jones GW, Scardino PT, Murphy GP (1992) The association of benign prostatic hyperplasia and cancer of the prostate. Cancer 70 [1 Suppl]: 291\u2013301","journal-title":"Cancer"},{"issue":"3","key":"986_CR18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.exger.2004.12.008","volume":"40","author":"G Untergasser","year":"2005","unstructured":"Untergasser G, Madersbacher S, Berger P (2005) Benign prostatic hyperplasia: age-related tissue-remodeling. Exp Gerontol 40(3): 121\u2013128","journal-title":"Exp Gerontol"},{"issue":"1","key":"986_CR19","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/oby.2006.21","volume":"14","author":"S Lee","year":"2006","unstructured":"Lee S, Min HG, Choi SH, Kim YJ, Oh SW, Kim YJ, et al (2006) Central obesity as a risk factor for prostatic hyperplasia. Obesity (Silver Spring) 14(1): 172\u2013179","journal-title":"Obesity (Silver Spring)"},{"issue":"2","key":"986_CR20","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/ajcn\/85.2.523","volume":"85","author":"S Rohrmann","year":"2007","unstructured":"Rohrmann S, Giovannucci E, Willett WC, Platz EA (2007) Fruit and vegetable consumption, intake of micronutrients, and benign prostatic hyperplasia in US men. Am J Clin Nutr 85(2): 523\u2013529","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"986_CR21","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/j.1464-410X.2006.06400.x","volume":"98","author":"AP Berger","year":"2006","unstructured":"Berger AP, Bartsch G, Deibl M, Alber H, Pachinger O, Fritsche G, et al (2006) Atherosclerosis as a risk factor for benign prostatic hyperplasia. BJU Int 98(5): 1038\u20131042","journal-title":"BJU Int"},{"issue":"2","key":"986_CR22","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.urology.2005.08.061","volume":"67","author":"RJ Mullan","year":"2006","unstructured":"Mullan RJ, Bergstralh EJ, Farmer SA, Jacobson DJ, Hebbring SJ, Cunningham JM, et al (2006) Growth factor, cytokine, and vitamin D receptor polymorphisms and risk of benign prostatic hyperplasia in a community-based cohort of men. Urology 67(2): 300\u2013305","journal-title":"Urology"},{"issue":"2","key":"986_CR23","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/path.2077","volume":"211","author":"N Sampson","year":"2007","unstructured":"Sampson N, Untergasser G, Plas E, Berger P (2007) The ageing male reproductive tract. J Pathol 211(2): 206\u2013218","journal-title":"J Pathol"},{"issue":"3","key":"986_CR24","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0960-0760(90)90487-6","volume":"37","author":"E Stoner","year":"1990","unstructured":"Stoner E (1990) The clinical development of a 5 alpha-reductase inhibitor, finasteride. J Steroid Biochem Mol Biol 37(3): 375\u2013378","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"6 Suppl 1","key":"986_CR25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0090-4295(01)01299-7","volume":"58","author":"WD Steers","year":"2001","unstructured":"Steers WD (2001) 5alpha-reductase activity in the prostate. Urology 58 [6 Suppl 1]: 17\u201324; discussion","journal-title":"Urology"},{"issue":"2","key":"986_CR26","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.juro.2007.09.084","volume":"179","author":"CG Roehrborn","year":"2008","unstructured":"Roehrborn CG, Siami P, Barkin J, Damiao R, Major-Walker K, Morrill B, et al (2008) The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the CombAT study. J Urol 179(2): 616\u2013621; discussion 21","journal-title":"J Urol"},{"issue":"2","key":"986_CR27","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1210\/jcem.87.2.8201","volume":"87","author":"HA Feldman","year":"2002","unstructured":"Feldman HA, Longcope C, Derby CA, Johannes CB, Araujo AB, Coviello AD, et al (2002) Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab 87(2): 589\u2013598","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"986_CR28","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1677\/joe.0.0450135","volume":"45","author":"DT Baird","year":"1969","unstructured":"Baird DT, Uno A, Melby JC (1969) Adrenal secretion of androgens and oestrogens. J Endocrinol 45(1): 135\u2013136","journal-title":"J Endocrinol"},{"issue":"2","key":"986_CR29","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/1078-0432.CCR-1146-03","volume":"10","author":"JL Mohler","year":"2004","unstructured":"Mohler JL, Gregory CW, Ford OH 3rd, Kim D, Weaver CM, Petrusz P, et al (2004) The androgen axis in recurrent prostate cancer. Clin Cancer Res 10(2): 440\u2013448","journal-title":"Clin Cancer Res"},{"issue":"21","key":"986_CR30","doi-asserted-by":"crossref","first-page":"7121","DOI":"10.1158\/1078-0432.CCR-04-0913","volume":"10","author":"T Nishiyama","year":"2004","unstructured":"Nishiyama T, Hashimoto Y, Takahashi K (2004) The influence of androgen deprivation therapy on dihydrotestosterone levels in the prostatic tissue of patients with prostate cancer. Clin Cancer Res 10(21): 7121\u20137126","journal-title":"Clin Cancer Res"},{"issue":"2","key":"986_CR31","first-page":"375","volume":"77","author":"M Krieg","year":"1993","unstructured":"Krieg M, Nass R, Tunn S (1993) Effect of aging on endogenous level of 5 alpha-dihydrotestosterone, testosterone, estradiol, and estrone in epithelium and stroma of normal and hyperplastic human prostate. J Clin Endocrinol Metab 77(2): 375\u2013381","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"986_CR32","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1002\/pros.20569","volume":"67","author":"P Wikstrom","year":"2007","unstructured":"Wikstrom P, Ohlson N, Stattin P, Bergh A (2007) Nuclear androgen receptors recur in the epithelial and stromal compartments of malignant and non-malignant human prostate tissue several months after castration therapy. Prostate 67(12): 1277\u20131284","journal-title":"Prostate"},{"issue":"4","key":"986_CR33","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.steroids.2007.01.004","volume":"72","author":"J Heracek","year":"2007","unstructured":"Heracek J, Richard H, Martin H, Luboslav S, Jana S, Jitka K, et al (2007) Tissue and serum levels of principal androgens in benign prostatic hyperplasia and prostate cancer. Steroids 72(4): 375\u2013380","journal-title":"Steroids"},{"issue":"12","key":"986_CR34","doi-asserted-by":"crossref","first-page":"5806","DOI":"10.1210\/en.2006-0627","volume":"147","author":"DR Bauman","year":"2006","unstructured":"Bauman DR, Steckelbroeck S, Peehl DM, Penning TM (2006) Transcript profiling of the androgen signal in normal prostate, benign prostatic hyperplasia, and prostate cancer. Endocrinology 147(12): 5806\u20135816","journal-title":"Endocrinology"},{"issue":"4","key":"986_CR35","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/pros.20362","volume":"66","author":"RO Roberts","year":"2006","unstructured":"Roberts RO, Bergstralh EJ, Farmer SA, Jacobson DJ, Hebbring SJ, Cunningham JM, et al (2006) Polymorphisms in genes involved in sex hormone metabolism may increase risk of benign prostatic hyperplasia. Prostate 66(4): 392\u2013404","journal-title":"Prostate"},{"key":"986_CR36","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/(SICI)1520-6408(1996)18:2<99::AID-DVG2>3.0.CO;2-W","volume":"18","author":"GS Prins","year":"1996","unstructured":"Prins GS, Jung MH, Vellanoweth RL, Chatterjee B, Roy AK (1996) Age-dependent expression of the androgen receptor gene in the prostate and its implication in glandular differentiation and hyperplasia. Dev Genet 18: 99\u2013106","journal-title":"Dev Genet"},{"key":"986_CR37","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/pros.10244","volume":"55","author":"LA Garraway","year":"2003","unstructured":"Garraway LA, Lin D, Signoretti S, Waltregny D, Dilks J, Bhattacharya N, et al (2003) Intermediate basal cells of the prostate: in vitro and in vivo characterization. Prostate 55: 206\u2013218","journal-title":"Prostate"},{"key":"986_CR38","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1210\/endo.142.9.8376","volume":"142","author":"PP Banerjee","year":"2001","unstructured":"Banerjee PP, Banerjee S, Brown TR (2001) Increased androgen receptor expression correlates with development of age-dependent, lobe-specific spontaneous hyperplasia of the brown Norway rat prostate. Endocrinology 142: 4066\u20134075","journal-title":"Endocrinology"},{"key":"986_CR39","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/(SICI)1097-0045(199602)28:2<98::AID-PROS4>3.0.CO;2-J","volume":"28","author":"H Bonkhoff","year":"1996","unstructured":"Bonkhoff H, Remberger K (1996) Differentiation pathways and histogenic aspects of normal and abnormal prostatic growth: a stem cell model. Prostate 28: 98\u2013106","journal-title":"Prostate"},{"issue":"2","key":"986_CR40","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/014850190518143","volume":"51","author":"EL Salazar","year":"2005","unstructured":"Salazar EL, Mercado E, Calzada L (2005) Prostatic cancer\/benign prostatic hypertrophy. Subcellular distribution of estradiol\/androgen receptors. Arch Androl 51(2): 135\u2013139","journal-title":"Arch Androl"},{"key":"986_CR41","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1349-7006.2007.00656.x","volume":"99","author":"M Uemura","year":"2008","unstructured":"Uemura M, Tamura K, Chung S, Honma S, Okuyama A, Nakamura Y, et al (2008) Novel 5alpha-steroid reductase (SRD5A3, type-3) is overexpressed in hormone-refractory prostate cancer. Cancer Sci 99: 81\u201386","journal-title":"Cancer Sci"},{"key":"986_CR42","first-page":"1203","volume":"77","author":"P Bonnet","year":"1993","unstructured":"Bonnet P, Reiter E, Bruyninx M, Sente B, Dombrowicz D, de Leval J, et al (1993) Benign prostatic hyperplasia and normal prostate ageing: differences in types I and II 5 alpha-reductase and steroid hormone receptor messenger ribonucleic acid (mRNA) levels, but not in insulin-like growth factor mRNA levels. J Clin Endocrinol Metab 77: 1203\u20131208","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"986_CR43","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/(SICI)1097-0045(20000101)42:1<45::AID-PROS6>3.0.CO;2-W","volume":"42","author":"Y Shibata","year":"2000","unstructured":"Shibata Y, Ito K, Suzuki K, Nakano K, Fukabori Y, Suzuki R, et al (2000) Changes in the endocrine environment of the human prostate transition zone with aging: simultaneous quantitative analysis of prostatic sex steroids and comparison with human prostatic histological composition. Prostate 42(1): 45\u201355","journal-title":"Prostate"},{"issue":"2","key":"986_CR44","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/(SICI)1097-0045(19970501)31:2<118::AID-PROS7>3.0.CO;2-J","volume":"31","author":"M Hiramatsu","year":"1997","unstructured":"Hiramatsu M, Maehara I, Ozaki M, Harada N, Orikasa S, Sasano H (1997) Aromatase in hyperplasia and carcinoma of the human prostate. Prostate 31(2): 118\u2013124","journal-title":"Prostate"},{"issue":"4","key":"986_CR45","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/(SICI)1097-0045(199610)29:4<199::AID-PROS1>3.0.CO;2-7","volume":"29","author":"A Radlmaier","year":"1996","unstructured":"Radlmaier A, Eickenberg HU, Fletcher MS, Fourcade RO, Reis Santos JM, van Aubel OG, et al (1996) Estrogen reduction by aromatase inhibition for benign prostatic hyperplasia: results of a double-blind, placebo-controlled, randomized clinical trial using two doses of the aromatase-inhibitor atamestane. Atamestane Study Group. Prostate 29(4): 199\u2013208","journal-title":"Prostate"},{"issue":"4","key":"986_CR46","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jsbmb.2004.10.016","volume":"92","author":"PL Harkonen","year":"2004","unstructured":"Harkonen PL, Makela SI (2004) Role of estrogens in development of prostate cancer. J Steroid Biochem Mol Biol 92(4): 297\u2013305","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"3","key":"986_CR47","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/jcb.10759","volume":"91","author":"SM Ho","year":"2004","unstructured":"Ho SM (2004) Estrogens and anti-estrogens: key mediators of prostate carcinogenesis and new therapeutic candidates. J Cell Biochem 91(3): 491\u2013503","journal-title":"J Cell Biochem"},{"issue":"4","key":"986_CR48","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1071\/RD01010","volume":"13","author":"GR Cunha","year":"2001","unstructured":"Cunha GR, Wang YZ, Hayward SW, Risbridger GP (2001) Estrogenic effects on prostatic differentiation and carcinogenesis. Reprod Fertil Dev 13(4): 285\u2013296","journal-title":"Reprod Fertil Dev"},{"issue":"11","key":"986_CR49","doi-asserted-by":"crossref","first-page":"6330","DOI":"10.1073\/pnas.111150898","volume":"98","author":"Z Weihua","year":"2001","unstructured":"Weihua Z, Makela S, Andersson LC, Salmi S, Saji S, Webster JI, et al (2001) A role for estrogen receptor beta in the regulation of growth of the ventral prostate. Proc Natl Acad Sci USA 98(11): 6330\u20136335","journal-title":"Proc Natl Acad Sci USA"},{"issue":"21","key":"986_CR50","doi-asserted-by":"crossref","first-page":"13589","DOI":"10.1073\/pnas.162477299","volume":"99","author":"Z Weihua","year":"2002","unstructured":"Weihua Z, Lathe R, Warner M, Gustafsson JA (2002) An endocrine pathway in the prostate, ERbeta, AR, 5alpha-androstane-3beta,17beta-diol, and CYP7B1, regulates prostate growth. Proc Natl Acad Sci USA 99(21): 13589\u201313594","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"986_CR51","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1210\/en.2006-0906","volume":"148","author":"SJ McPherson","year":"2007","unstructured":"McPherson SJ, Ellem SJ, Simpson ER, Patchev V, Fritzemeier KH, Risbridger GP (2007) Essential role for estrogen receptor beta in stromal-epithelial regulation of prostatic hyperplasia. Endocrinology 148(2): 566\u2013574","journal-title":"Endocrinology"},{"key":"986_CR52","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1097\/01.ju.0000176459.79180.d1","volume":"174","author":"SF Shariat","year":"2005","unstructured":"Shariat SF, Ashfaq R, Roehrborn C, Slawin KM, Lotan Y (2005) Expression of survivin and apoptotic biomarkers in benign prostatic hyperplasia. J Urol 174: 2046\u20132050","journal-title":"J Urol"},{"issue":"3","key":"986_CR53","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1053\/hupa.2002.32227","volume":"33","author":"M Royuela","year":"2002","unstructured":"Royuela M, Arenas MI, Bethencourt FR, Sanchez-Chapado M, Fraile B, Paniagua R (2002) Regulation of proliferation\/apoptosis equilibrium by mitogen-activated protein kinases in normal, hyperplastic, and carcinomatous human prostate. Hum Pathol 33(3): 299\u2013306","journal-title":"Hum Pathol"},{"issue":"17","key":"986_CR54","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1093\/jnci\/90.17.1284","volume":"90","author":"C Cordon-Cardo","year":"1998","unstructured":"Cordon-Cardo C, Koff A, Drobnjak M, Capodieci P, Osman I, Millard SS, et al (1998) Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma. J Natl Cancer Inst 90(17): 1284\u20131291","journal-title":"J Natl Cancer Inst"},{"key":"986_CR55","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/pros.10143","volume":"53","author":"EM Bruckheimer","year":"2002","unstructured":"Bruckheimer EM, Kyprianou N (2002) Bcl-2 antagonises the combined apoptotic effect of transforming growth factor beta and dihydrotestosterone in prostate cancer cells. Prostate 53: 133\u2013142","journal-title":"Prostate"},{"issue":"7","key":"986_CR56","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0046-8177(96)90396-2","volume":"27","author":"N Kyprianou","year":"1996","unstructured":"Kyprianou N, Tu H, Jacobs SC (1996) Apoptotic versus proliferative activities in human benign prostatic hyperplasia. Hum Pathol 27(7): 668\u2013675","journal-title":"Hum Pathol"},{"issue":"1","key":"986_CR57","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.mad.2004.09.023","volume":"126","author":"G Untergasser","year":"2005","unstructured":"Untergasser G, Gander R, Lilg C, Lepperdinger G, Plas E, Berger P (2005) Profiling molecular targets of TGF-beta1 in prostate fibroblast-to-myofibroblast transdifferentiation. Mech Ageing Dev 126(1): 59\u201369","journal-title":"Mech Ageing Dev"},{"issue":"9","key":"986_CR58","first-page":"2912","volume":"8","author":"JA Tuxhorn","year":"2002","unstructured":"Tuxhorn JA, Ayala GE, Smith MJ, Smith VC, Dang TD, Rowley DR (2002) Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling. Clin Cancer Res 8(9): 2912\u20132923","journal-title":"Clin Cancer Res"},{"key":"986_CR59","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1210\/en.2004-1123","volume":"146","author":"WW Barclay","year":"2005","unstructured":"Barclay WW, Woodruff RD, Hall MC, Cramer SD (2005) A system for studying epithelial-stromal interactions reveals distinct inductive abilities of stromal cells from benign prostatic hyperplasia and prostate cancer. Endocrinology 146: 13\u201318","journal-title":"Endocrinology"},{"key":"986_CR60","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.cell.2005.02.034","volume":"121","author":"A Orimo","year":"2005","unstructured":"Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, et al (2005) Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1\/CXCL12 secretion. Cell 121: 335\u2013348","journal-title":"Cell"},{"issue":"1","key":"986_CR61","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0002-9440(10)64535-X","volume":"157","author":"D Giri","year":"2000","unstructured":"Giri D, Ittmann M (2000) Interleukin-1alpha is a paracrine inducer of FGF7, a key epithelial growth factor in benign prostatic hyperplasia. Am J Pathol 157(1): 249\u2013255","journal-title":"Am J Pathol"},{"issue":"2","key":"986_CR62","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0022-5347(05)68632-6","volume":"162","author":"F Ropiquet","year":"1999","unstructured":"Ropiquet F, Giri D, Lamb DJ, Ittmann M (1999) FGF7 and FGF2 are increased in benign prostatic hyperplasia and are associated with increased proliferation. J Urol 162(2): 595\u2013599","journal-title":"J Urol"},{"issue":"1","key":"986_CR63","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0002-9440(10)61681-1","volume":"159","author":"D Giri","year":"2001","unstructured":"Giri D, Ittmann M (2001) Interleukin-8 is a paracrine inducer of fibroblast growth factor 2, a stromal and epithelial growth factor in benign prostatic hyperplasia. Am J Pathol 159(1): 139\u2013147","journal-title":"Am J Pathol"},{"key":"986_CR64","first-page":"329","volume":"39","author":"MC Pollan","year":"2003","unstructured":"Pollan MC, Benghuzzi HA, Tucci M (2003) Growth factor expression in early stages of benign prostatic hyperplasia upon exposure to sustained delivery of androgens. Biomed Sci Instrum 39: 329\u2013334","journal-title":"Biomed Sci Instrum"},{"issue":"1","key":"986_CR65","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1083\/jcb.200412015","volume":"170","author":"SN Salm","year":"2005","unstructured":"Salm SN, Burger PE, Coetzee S, Goto K, Moscatelli D, Wilson EL (2005) TGF-{beta} maintains dormancy of prostatic stem cells in the proximal region of ducts. J Cell Biol 170(1): 81\u201390","journal-title":"J Cell Biol"},{"key":"986_CR66","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1196\/annals.1386.006","volume":"1089","author":"A Migliaccio","year":"2006","unstructured":"Migliaccio A, Castoria G, Di Domenico M, Ciociola A, Lombardi M, De Falco A, et al (2006) Crosstalk between EGFR and extranuclear steroid receptors. Ann N Y Acad Sci 1089: 194\u2013200","journal-title":"Ann N Y Acad Sci"},{"key":"986_CR67","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1158\/0008-5472.CAN-04-1837","volume":"65","author":"G Pandini","year":"2005","unstructured":"Pandini G, Mineo R, Frasca F, Roberts CT, Marcelli M, Vigneri R, et al (2005) Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells. Cancer Res 65: 1849\u20131857","journal-title":"Cancer Res"},{"issue":"5","key":"986_CR68","doi-asserted-by":"crossref","first-page":"E952","DOI":"10.1152\/ajpendo.00451.2005","volume":"290","author":"H Le","year":"2006","unstructured":"Le H, Arnold JT, McFann KK, Blackman MR (2006) DHT and testosterone, but not DHEA or E2, differentially modulate IGF-I, IGFBP-2, and IGFBP-3 in human prostatic stromal cells. Am J Physiol Endocrinol Metab 290(5): E952\u2013E960","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"986_CR69","doi-asserted-by":"crossref","unstructured":"Wu JD, Haugk K, Woodke L, Nelson PS, Coleman I, Plymate S (2006) Interaction of IGF signaling and the androgen receptor in prostate cancer progression. J Cell Biochem 25: epub","DOI":"10.1002\/jcb.20929"},{"key":"986_CR70","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.eururo.2005.09.006","volume":"48","author":"HG van der Poel","year":"2005","unstructured":"van der Poel HG (2005) Androgen receptor and TGF-beta1\/Smad signaling are mutually inhibitory in prostate cancer. Eur Urol 48: 1051\u20131058","journal-title":"Eur Urol"},{"key":"986_CR71","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1210\/me.2003-0360","volume":"18","author":"JL Carey","year":"2004","unstructured":"Carey JL, Sasur LM, Kawakubo H, Gupta V, Christian B, Bailey PM, et al (2004) Mutually antagonistic effects of androgen and activin in the regulation of prostate cancer cell growth. Mol Endocrinol 18: 696\u2013707","journal-title":"Mol Endocrinol"},{"issue":"11","key":"986_CR72","first-page":"2731","volume":"59","author":"G Brodin","year":"1999","unstructured":"Brodin G, ten Dijke P, Funa K, Heldin CH, Landstrom M (1999) Increased smad expression and activation are associated with apoptosis in normal and malignant prostate after castration. Cancer Res 59(11): 2731\u20132738","journal-title":"Cancer Res"},{"issue":"43","key":"986_CR73","doi-asserted-by":"crossref","first-page":"36355","DOI":"10.1074\/jbc.M506147200","volume":"280","author":"G Chen","year":"2005","unstructured":"Chen G, Nomura M, Morinaga H, Matsubara E, Okabe T, Goto K, et al (2005) Modulation of androgen receptor transactivation by FoxH1. A newly identified androgen receptor corepressor. J Biol Chem 280(43): 36355\u201336363","journal-title":"J Biol Chem"},{"issue":"1","key":"986_CR74","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.mad.2006.11.012","volume":"128","author":"N Sampson","year":"2007","unstructured":"Sampson N, Untergasser G, Lilg C, Tadic L, Plas E, Berger P (2007) GAGEC1, a cancer\/testis associated antigen family member, is a target of TGF-beta1 in age-related prostatic disease. Mech Ageing Dev 128(1): 64\u201366","journal-title":"Mech Ageing Dev"},{"issue":"5","key":"986_CR75","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.eururo.2006.12.011","volume":"51","author":"G Kramer","year":"2007","unstructured":"Kramer G, Mitteregger D, Marberger M (2007) Is benign prostatic hyperplasia (BPH) an immune inflammatory disease? Eur Urol 51(5): 1202\u20131216","journal-title":"Eur Urol"},{"issue":"3","key":"986_CR76","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/pros.10224","volume":"55","author":"DG Bostwick","year":"2003","unstructured":"Bostwick DG, de la Roza G, Dundore P, Corica FA, Iczkowski KA (2003) Intraepithelial and stromal lymphocytes in the normal human prostate. Prostate 55(3): 187\u2013193","journal-title":"Prostate"},{"issue":"1","key":"986_CR77","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0022-5347(05)67987-6","volume":"163","author":"WW Hochreiter","year":"2000","unstructured":"Hochreiter WW, Duncan JL, Schaeffer AJ (2000) Evaluation of the bacterial flora of the prostate using a 16S rRNA gene based polymerase chain reaction. J Urol 163(1): 127\u2013130","journal-title":"J Urol"},{"issue":"2","key":"986_CR78","first-page":"501","volume":"149","author":"L Mazzucchelli","year":"1996","unstructured":"Mazzucchelli L, Loetscher P, Kappeler A, Uguccioni M, Baggiolini M, Laissue JA, et al (1996) Monocyte chemoattractant protein-1 gene expression in prostatic hyperplasia and prostate adenocarcinoma. Am J Pathol 149(2): 501\u2013509","journal-title":"Am J Pathol"},{"issue":"6","key":"986_CR79","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1474-9726.2005.00173.x","volume":"4","author":"L Begley","year":"2005","unstructured":"Begley L, Monteleon C, Shah RB, Macdonald JW, Macoska JA (2005) CXCL12 overexpression and secretion by aging fibroblasts enhance human prostate epithelial proliferation in vitro. Aging Cell 4(6): 291\u2013298","journal-title":"Aging Cell"},{"key":"986_CR80","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/pros.20424","volume":"66","author":"S Lu","year":"2006","unstructured":"Lu S, Dong Z (2006) Characterization of TGF-beta-regulated interleukin-8 expression in human prostate cancer cells. Prostate 66: 996\u20131004","journal-title":"Prostate"},{"issue":"2","key":"986_CR81","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/pros.20051","volume":"60","author":"P Castro","year":"2004","unstructured":"Castro P, Xia C, Gomez L, Lamb DJ, Ittmann M (2004)Interleukin-8 expression is increased in senescent prostatic epithelial cells and promotes the development of benign prostatic hyperplasia. Prostate 60(2): 153\u2013159","journal-title":"Prostate"},{"issue":"1","key":"986_CR82","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/pros.20061","volume":"61","author":"W Wang","year":"2004","unstructured":"Wang W, Bergh A, Damber JE (2004) Chronic inflammation in benign prostate hyperplasia is associated with focal upregulation of cyclooxygenase-2, Bcl-2, and cell proliferation in the glandular epithelium. Prostate 61(1): 60\u201372","journal-title":"Prostate"},{"issue":"1","key":"986_CR83","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.eururo.2004.08.024","volume":"47","author":"F Di Silverio","year":"2005","unstructured":"Di Silverio F, Bosman C, Salvatori M, Albanesi L, Proietti Pannunzi L, Ciccariello M, et al (2005) Combination therapy with rofecoxib and finasteride in the treatment of men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH). Eur Urol 47(1): 72\u201378; discussion 8\u20139","journal-title":"Eur Urol"},{"key":"986_CR84","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/pros.2990120310","volume":"12","author":"CL Robinette","year":"1988","unstructured":"Robinette CL (1988) Sex-hormone induced inflammation and fibromuscular proliferation in the rat lateral prostate. Prostate 12: 271\u2013286","journal-title":"Prostate"},{"issue":"1","key":"986_CR85","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1210\/en.2005-0942","volume":"147","author":"AJ Asirvatham","year":"2006","unstructured":"Asirvatham AJ, Schmidt M, Gao B, Chaudhary J (2006)Androgens regulate the immune\/inflammatory response and cell survival pathways in rat ventral prostate epithelial cells. Endocrinology 147(1): 257\u2013271","journal-title":"Endocrinology"},{"issue":"3","key":"986_CR86","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.cell.2005.12.032","volume":"124","author":"P Zhu","year":"2006","unstructured":"Zhu P, Baek SH, Bourk EM, Ohgi KA, Garcia-Bassets I, Sanjo H, et al (2006) Macrophage\/cancer cell interactions mediate hormone resistance by a nuclear receptor derepression pathway. Cell 124(3): 615\u2013629","journal-title":"Cell"},{"issue":"8","key":"986_CR87","doi-asserted-by":"crossref","first-page":"4516","DOI":"10.1158\/0008-5472.CAN-05-3796","volume":"66","author":"L Nonn","year":"2006","unstructured":"Nonn L, Peng L, Feldman D, Peehl DM (2006) Inhibition of p38 by vitamin D reduces interleukin-6 production in normal prostate cells via mitogen-activated protein kinase phosphatase 5: implications for prostate cancer prevention by vitamin D. Cancer Res 66(8): 4516\u20134524","journal-title":"Cancer Res"},{"key":"986_CR88","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1093\/carcin\/bgl041","volume":"27","author":"BY Bao","year":"2006","unstructured":"Bao BY, Yao J, Lee YF (2006) 1{alpha}, 25-dihydroxyvitamin D3 suppresses interleukin-8-mediated prostate cancer cell angiogenesis. Carcinogenesis 27: 1883\u20131893","journal-title":"Carcinogenesis"},{"issue":"2","key":"986_CR89","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1210\/jc.2004-1496","volume":"90","author":"C Crescioli","year":"2005","unstructured":"Crescioli C, Morelli A, Adorini L, Ferruzzi P, Luconi M, Vannelli GB, et al (2005) Human bladder as a novel target for vitamin D receptor ligands. J Clin Endocrinol Metab 90(2): 962\u2013972","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"986_CR90","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.biocel.2006.07.001","volume":"39","author":"M Valko","year":"2007","unstructured":"Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39(1): 44\u201384","journal-title":"Int J Biochem Cell Biol"},{"issue":"18\u201319","key":"986_CR91","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/S0024-3205(99)00439-7","volume":"65","author":"L Bergendi","year":"1999","unstructured":"Bergendi L, Benes L, Durackova Z, Ferencik M (1999) Chemistry, physiology and pathology of free radicals. Life Sci 65(18\u201319): 1865\u20131874","journal-title":"Life Sci"},{"issue":"4","key":"986_CR92","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/sj.pcan.4500965","volume":"10","author":"K Goswami","year":"2007","unstructured":"Goswami K, Nandeesha H, Koner BC, Nandakumar DN (2007) A comparative study of serum protein-bound sialic acid in benign and malignant prostatic growth: possible role of oxidative stress in sialic acid homeostasis. Prostate Cancer Prostatic Dis 10(4): 356\u2013359","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"2","key":"986_CR93","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/0962935031000097745","volume":"12","author":"RA Merendino","year":"2003","unstructured":"Merendino RA, Salvo F, Saija A, Di Pasquale G, Tomaino A, Minciullo PL, et al (2003) Malondialdehyde in benign prostate hypertrophy: a useful marker? Mediators Inflamm 12(2): 127\u2013128","journal-title":"Mediators Inflamm"},{"issue":"2","key":"986_CR94","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/(SICI)1096-9896(199910)189:2<224::AID-PATH422>3.0.CO;2-K","volume":"189","author":"R Gradini","year":"1999","unstructured":"Gradini R, Realacci M, Ginepri A, Naso G, Santangelo C, Cela O, et al (1999) Nitric oxide synthases in normal and benign hyperplastic human prostate: immunohistochemistry and molecular biology. J Pathol 189(2): 224\u2013229","journal-title":"J Pathol"},{"issue":"5","key":"986_CR95","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1016\/S0022-5347(05)65664-9","volume":"166","author":"AR Shahed","year":"2001","unstructured":"Shahed AR, Shoskes DA (2001) Correlation of beta-endorphin and prostaglandin E2 levels in prostatic fluid of patients with chronic prostatitis with diagnosis and treatment response. J Urol 166(5): 1738\u20131741","journal-title":"J Urol"},{"issue":"5","key":"986_CR96","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1439-0272.2003.tb00862.x","volume":"35","author":"JM Potts","year":"2003","unstructured":"Potts JM, Pasqualotto FF (2003) Seminal oxidative stress in patients with chronic prostatitis. Andrologia 35(5): 304\u2013308","journal-title":"Andrologia"},{"issue":"2\u20133","key":"986_CR97","first-page":"206","volume":"448","author":"PF Li","year":"1999","unstructured":"Li PF, Dietz R, von Harsdorf R (1999) Superoxide induces apoptosis in cardiomyocytes, but proliferation and expression of transforming growth factor-beta1 in cardiac fibroblasts. FEBS Lett 448(2\u20133): 206\u2013210","journal-title":"FEBS Lett"},{"issue":"51","key":"986_CR98","doi-asserted-by":"crossref","first-page":"30334","DOI":"10.1074\/jbc.270.51.30334","volume":"270","author":"VJ Thannickal","year":"1995","unstructured":"Thannickal VJ, Fanburg BL (1995) Activation of an H2O2-generating NADH oxidase in human lung fibroblasts by transforming growth factor beta 1. J Biol Chem 270(51): 30334\u201330338","journal-title":"J Biol Chem"},{"issue":"20","key":"986_CR99","doi-asserted-by":"crossref","first-page":"11715","DOI":"10.1073\/pnas.95.20.11715","volume":"95","author":"NS Chandel","year":"1998","unstructured":"Chandel NS, Maltepe E, Goldwasser E, Mathieu CE, Simon MC, Schumacker PT (1998) Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc Natl Acad Sci USA 95(20): 11715\u201311720","journal-title":"Proc Natl Acad Sci USA"},{"key":"986_CR100","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0076-6879(07)35022-2","volume":"435","author":"A Gorlach","year":"2007","unstructured":"Gorlach A, Kietzmann T (2007) Superoxide and derived reactive oxygen species in the regulation of hypoxia-inducible factors. Methods Enzymol 435: 421\u2013446","journal-title":"Methods Enzymol"},{"issue":"4\u20135","key":"986_CR101","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.semcdb.2005.03.010","volume":"16","author":"T Kietzmann","year":"2005","unstructured":"Kietzmann T, Gorlach A (2005) Reactive oxygen species in the control of hypoxia-inducible factor-mediated gene expression. Semin Cell Dev Biol 16(4\u20135): 474\u2013486","journal-title":"Semin Cell Dev Biol"},{"issue":"6","key":"986_CR102","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1113\/expphysiol.2005.030924","volume":"90","author":"PH Maxwell","year":"2005","unstructured":"Maxwell PH (2005) Hypoxia-inducible factor as a physiological regulator. Exp Physiol 90(6): 791\u2013797","journal-title":"Exp Physiol"},{"issue":"6B","key":"986_CR103","first-page":"4729","volume":"18","author":"C Riva","year":"1998","unstructured":"Riva C, Chauvin C, Pison C, Leverve X (1998) Cellular physiology and molecular events in hypoxia-induced apoptosis. Anticancer Res 18(6B): 4729\u20134736","journal-title":"Anticancer Res"},{"issue":"9","key":"986_CR104","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1161\/01.RES.0000187457.24338.3D","volume":"97","author":"I Cucoranu","year":"2005","unstructured":"Cucoranu I, Clempus R, Dikalova A, Phelan PJ, Ariyan S, Dikalov S, et al (2005) NAD(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts. Circ Res 97(9): 900\u2013907","journal-title":"Circ Res"},{"issue":"Pt 13","key":"986_CR105","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1242\/jcs.03011","volume":"119","author":"B Cat","year":"2006","unstructured":"Cat B, Stuhlmann D, Steinbrenner H, Alili L, Holtkotter O, Sies H, et al (2006) Enhancement of tumor invasion depends on transdifferentiation of skin fibroblasts mediated by reactive oxygen species. J Cell Sci 119(Pt 13): 2727\u20132738","journal-title":"J Cell Sci"},{"issue":"1","key":"986_CR106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pros.10169","volume":"55","author":"NN Tam","year":"2003","unstructured":"Tam NN, Ghatak S, Ho SM (2003) Sex hormone-induced alterations in the activities of antioxidant enzymes and lipid peroxidation status in the prostate of Noble rats. Prostate 55(1): 1\u20138","journal-title":"Prostate"},{"issue":"4","key":"986_CR107","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.2353\/ajpath.2007.070199","volume":"171","author":"NN Tam","year":"2007","unstructured":"Tam NN, Leav I, Ho SM (2007) Sex hormones induce direct epithelial and inflammation-mediated oxidative\/nitrosative stress that favors prostatic carcinogenesis in the noble rat. Am J Pathol 171(4): 1334\u20131341","journal-title":"Am J Pathol"},{"issue":"4","key":"986_CR108","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/15287390600974924","volume":"10","author":"D Roy","year":"2007","unstructured":"Roy D, Cai Q, Felty Q, Narayan S (2007) Estrogen-induced generation of reactive oxygen and nitrogen species, gene damage, and estrogen-dependent cancers. J Toxicol Environ Health B Crit Rev 10(4): 235\u2013257","journal-title":"J Toxicol Environ Health B Crit Rev"},{"issue":"6","key":"986_CR109","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/S0022-5347(17)38203-4","volume":"146","author":"CR Chapple","year":"1991","unstructured":"Chapple CR, Crowe R, Gilpin SA, Gosling J, Burnstock G (1991) The innervation of the human prostate gland \u2013 the changes associated with benign enlargement. J Urol 146(6): 1637\u20131644","journal-title":"J Urol"},{"issue":"6","key":"986_CR110","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0022-5347(17)50110-X","volume":"132","author":"H Lepor","year":"1984","unstructured":"Lepor H, Shapiro E (1984) Characterization of alpha1 adrenergic receptors in human benign prostatic hyperplasia. J Urol 132(6): 1226\u20131229","journal-title":"J Urol"},{"issue":"3","key":"986_CR111","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0090-4295(99)80012-0","volume":"45","author":"AL Burnett","year":"1995","unstructured":"Burnett AL, Maguire MP, Chamness SL, Ricker DD, Takeda M, Lepor H, et al (1995) Characterization and localization of nitric oxide synthase in the human prostate. Urology 45(3): 435\u2013439","journal-title":"Urology"},{"issue":"3","key":"986_CR112","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/j.1939-4640.1998.tb02016.x","volume":"19","author":"JK Crone","year":"1998","unstructured":"Crone JK, Burnett AL, Chamness SL, Strandberg JD, Chang TS (1998) Neuronal nitric oxide synthase in the canine prostate: aging, sex steroid, and pathology correlations. J Androl 19(3): 358\u2013364","journal-title":"J Androl"},{"issue":"3","key":"986_CR113","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/01.RES.0000256354.95791.f1","volume":"100","author":"K Omori","year":"2007","unstructured":"Omori K, Kotera J (2007) Overview of PDEs and their regulation. Circ Res 100(3): 309\u2013327","journal-title":"Circ Res"},{"issue":"6","key":"986_CR114","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s00345-005-0017-3","volume":"23","author":"S Uckert","year":"2005","unstructured":"Uckert S, Stief CG, Mayer M, Jonas U, Hedlund P (2005) Distribution and functional significance of phosphodiesterase isoenzymes in the human lower urinary tract. World J Urol 23(6): 368\u2013373","journal-title":"World J Urol"},{"issue":"3","key":"986_CR115","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.juro.2006.10.055","volume":"177","author":"KT McVary","year":"2007","unstructured":"McVary KT, Monnig W, Camps JL Jr, Young JM, Tseng LJ, van den Ende G (2007) Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized, double-blind trial. J Urol 177(3): 1071\u20131077","journal-title":"J Urol"},{"key":"986_CR116","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.mce.2006.12.007","volume":"265\u2013266","author":"TM Penning","year":"2007","unstructured":"Penning TM, Bauman DR, Jin Y, Rizner TL (2007) Identification of the molecular switch that regulates access of 5alpha-DHT to the androgen receptor. Mol Cell Endocrinol 265\u2013266: 77\u201382","journal-title":"Mol Cell Endocrinol"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-008-0986-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00508-008-0986-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-008-0986-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T13:14:16Z","timestamp":1709212456000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00508-008-0986-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":116,"journal-issue":{"issue":"13-14","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["986"],"URL":"https:\/\/doi.org\/10.1007\/s00508-008-0986-5","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7]]},"article-number":"390"}}